全文获取类型
收费全文 | 3548篇 |
免费 | 264篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 86篇 |
妇产科学 | 105篇 |
基础医学 | 648篇 |
口腔科学 | 70篇 |
临床医学 | 379篇 |
内科学 | 767篇 |
皮肤病学 | 110篇 |
神经病学 | 380篇 |
特种医学 | 83篇 |
外科学 | 316篇 |
综合类 | 24篇 |
一般理论 | 3篇 |
预防医学 | 339篇 |
眼科学 | 41篇 |
药学 | 226篇 |
中国医学 | 6篇 |
肿瘤学 | 217篇 |
出版年
2024年 | 2篇 |
2023年 | 55篇 |
2022年 | 65篇 |
2021年 | 125篇 |
2020年 | 75篇 |
2019年 | 127篇 |
2018年 | 163篇 |
2017年 | 109篇 |
2016年 | 113篇 |
2015年 | 135篇 |
2014年 | 171篇 |
2013年 | 219篇 |
2012年 | 313篇 |
2011年 | 313篇 |
2010年 | 174篇 |
2009年 | 186篇 |
2008年 | 240篇 |
2007年 | 234篇 |
2006年 | 213篇 |
2005年 | 205篇 |
2004年 | 163篇 |
2003年 | 140篇 |
2002年 | 112篇 |
2001年 | 10篇 |
2000年 | 8篇 |
1999年 | 27篇 |
1998年 | 29篇 |
1997年 | 16篇 |
1996年 | 3篇 |
1995年 | 12篇 |
1994年 | 6篇 |
1993年 | 5篇 |
1992年 | 8篇 |
1991年 | 7篇 |
1990年 | 5篇 |
1989年 | 1篇 |
1988年 | 1篇 |
1987年 | 1篇 |
1986年 | 8篇 |
1985年 | 2篇 |
1984年 | 4篇 |
1983年 | 4篇 |
1980年 | 1篇 |
1978年 | 2篇 |
1977年 | 3篇 |
1976年 | 1篇 |
1975年 | 1篇 |
1972年 | 1篇 |
1969年 | 1篇 |
1964年 | 1篇 |
排序方式: 共有3820条查询结果,搜索用时 15 毫秒
101.
Ricardo A. Chvez Montes Anna Haber Jeremy Pardo Robyn F. Powell Upendra K. Divisetty Anderson T. Silva Tania Hernndez-Hernndez Vanildo Silveira Haibao Tang Eric Lyons Luis Rafael Herrera Estrella Robert VanBuren Melvin J. Oliver 《Proceedings of the National Academy of Sciences of the United States of America》2022,119(5)
102.
103.
Velázquez-Pérez Luis Medrano-Montero Jacqueline Rodríguez-Labrada Roberto Canales-Ochoa Nalia Campins Alí Jandy Carrillo Rodes Frank J Rodríguez Graña Tania Hernández Oliver María O. Aguilera Rodríguez Raul Domínguez Barrios Yennis Torres Vega Reydenis Flores Angulo Lissi Cordero Navarro Noharis Y. Sigler Villanueva Aldo A. Gámez Rodríguez Osiel Sagaró Zambrano Ilya Navas Napóles Nayime Y. García Zacarías Javier Serrano Barrera Orlando R. Ramírez Bautista María B. Estupiñán Rodríguez Annelié Guerra Rondón Leonardo A. Vázquez-Mojena Yaimeé González-Zaldivar Yanetza Almaguer Mederos Luis E. Leyva-Mérida Alejandro 《Cerebellum (London, England)》2020,19(2):252-264
The Cerebellum - The prevalence estimations of hereditary ataxias are biased since most epidemiological studies are confined to isolated geographical regions and few nationwide studies are... 相似文献
104.
Havla Joachim Moser Marlene Sztatecsny Clara Lotz-Havla Amelie S. Maier Esther M. Hizli Baccara Schinner Regina Kümpfel Tania Strupp Michael Bremova-Ertl Tatiana Schneider Susanne A. 《Journal of neurology》2020,267(7):2070-2082
Journal of Neurology - Niemann–Pick disease type C1 (NPC1) is a rare autosomal-recessive lysosomal storage disorder presenting with a broad clinical spectrum ranging from a severe... 相似文献
105.
Federica Miglietta Maria Vittoria Dieci Vassilena Tsvetkova Gaia Griguolo Grazia Vernaci Alice Menichetti Giovanni Faggioni Tommaso Giarratano Eleonora Mioranza Elisa Genovesi Enrico Cumerlato Michele Bottosso Tania Saibene Silvia Michieletto Marcello Lo Mele Pierfranco Conte Valentina Guarneri 《The oncologist》2020,25(9):e1355-e1362
106.
107.
Serum markers detect the presence of liver fibrosis: a cohort study 总被引:47,自引:0,他引:47
Rosenberg WM Voelker M Thiel R Becka M Burt A Schuppan D Hubscher S Roskams T Pinzani M Arthur MJ;European Liver Fibrosis Group 《Gastroenterology》2004,127(6):1704-1713
BACKGROUND & AIMS: Histologic examination of a liver biopsy specimen is regarded as the reference standard for detecting liver fibrosis. Biopsy can be painful and hazardous, and assessment is subjective and prone to sampling error. We developed a panel of sensitive automated immunoassays to detect matrix constituents and mediators of matrix remodeling in serum to evaluate their performance in the detection of liver fibrosis. METHODS: In an international multicenter cohort study, serum levels of 9 surrogate markers of liver fibrosis were compared with fibrosis stage in liver biopsy specimens obtained from 1021 subjects with chronic liver disease. Discriminant analysis of a test set of samples was used to identify an algorithm combining age, hyaluronic acid, amino-terminal propeptide of type III collagen, and tissue inhibitor of matrix metalloproteinase 1 that was subsequently evaluated using a validation set of biopsy specimens and serum samples. RESULTS: The algorithm detected fibrosis (sensitivity, 90%) and accurately detected the absence of fibrosis (negative predictive value for significant fibrosis, 92%; area under the curve of a receiver operating characteristic plot, .804; standard error, .02; P < .0001; 95% confidence interval, .758-.851). Performance was excellent for alcoholic liver disease and nonalcoholic fatty liver disease. The algorithm performed equally well in comparison with each of the pathologists. In contrast, pathologists' agreement over histologic scores ranged from very good to moderate (kappa = .97-.46). CONCLUSIONS: Assessment of liver fibrosis with multiple serum markers used in combination is sensitive, specific, and reproducible, suggesting they may be used in conjunction with liver biopsy to assess a range of chronic liver diseases. 相似文献
108.
Laetitia Dard Christophe Hubert Pauline Esteves Wendy Blanchard Ghina Bou About Lyla Baldasseroni Elodie Dumon Chloe Angelini Mgane Delourme Vronique Guyonnet-Duprat Stphane Claverol Laura Fontenille Karima Kissa Pierre-Emmanuel Sgula Jean-Benoît Thambo Lvy Nicolas Yann Herault Nadge Bellance Nivea Dias Amoedo Frdrique Magdinier Tania Sorg Didier Lacombe Rodrigue Rossignol 《The Journal of clinical investigation》2022,132(8)
Germline mutations that activate genes in the canonical RAS/MAPK signaling pathway are responsible for rare human developmental disorders known as RASopathies. Here, we analyzed the molecular determinants of Costello syndrome (CS) using a mouse model expressing HRAS p.G12S, patient skin fibroblasts, hiPSC-derived human cardiomyocytes, a HRAS p.G12V zebrafish model, and human fibroblasts expressing lentiviral constructs carrying HRAS p.G12S or HRAS p.G12A mutations. The findings revealed alteration of mitochondrial proteostasis and defective oxidative phosphorylation in the heart and skeletal muscle of CS mice that were also found in the cell models of the disease. The underpinning mechanisms involved the inhibition of the AMPK signaling pathway by mutant forms of HRAS, leading to alteration of mitochondrial proteostasis and bioenergetics. Pharmacological activation of mitochondrial bioenergetics and quality control restored organelle function in HRAS p.G12A and p.G12S cell models, reduced left ventricle hypertrophy in CS mice, and diminished the occurrence of developmental defects in the CS zebrafish model. Collectively, these findings highlight the importance of mitochondrial proteostasis and bioenergetics in the pathophysiology of RASopathies and suggest that patients with CS may benefit from treatment with mitochondrial modulators. 相似文献
109.
Quatrehomme Gérald Toupenay Steve Delabarde Tania Padovani Bernard Alunni Véronique 《International journal of legal medicine》2019,133(1):277-287
International Journal of Legal Medicine - The terrorist attack of July 14, 2016 in Nice (France) was a devastating event. A man voluntarily drove a truck into a crowd gathered for the fireworks... 相似文献